RetinalGenix Technologies (RTGN) EPS (Weighted Average and Diluted) (2022 - 2026)

RetinalGenix Technologies has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$0.03 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.03, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.12 (up 22.5% YoY), and the FY2025 annual result was -$0.13, up 45.83% from the prior year.
• EPS (Weighted Average and Diluted) came in at -$0.03 for Q1 2026 at RetinalGenix Technologies, roughly flat from -$0.03 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.02 in Q2 2022 to a low of -$0.15 in Q3 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is -$0.03 (2023), against an average of -$0.05.
• Across the five-year window, EPS (Weighted Average and Diluted) plunged 300.0% in 2024 and jumped 75.0% in 2025, its largest moves.
• RetinalGenix Technologies' EPS (Weighted Average and Diluted) stood at -$0.04 in 2022, then gained by 25.0% to -$0.03 in 2023, then plunged by 66.67% to -$0.05 in 2024, then surged by 40.0% to -$0.03 in 2025, then changed by 0.0% to -$0.03 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.03 (Q1 2026), -$0.03 (Q4 2025), and -$0.03 (Q3 2025), per Business Quant data.